Skip to main content

Protein-Polysaccharide Conjugation

  • Protocol
Meningococcal Vaccines

Part of the book series: Methods in Molecular Medicineā„¢ ((MIMM,volume 66))

Abstract

The use of bacterial capsular polysaccharides as immunoprophylactic agents in human diseases caused by encapsulated bacteria is now firmly established (1). However, despite their many advantages, they do have serious limitations. First, they induce an inadequate immune response in infants (2), the section of the population most vulnerable to bacterial meningitis, and second, some polysaccharides are only weakly immunogenic in adults. To overcome these deficiencies, a new generation of semisynthetic vaccines have been developed based on the conjugation of polysaccharide to protein carriers.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Jennings, H. J. (1990) Capsular polysaccharides as vaccine candidates. Curr. Top. Microbiol. Immunol. 150, 97ā€“127.

    CASĀ  PubMedĀ  Google ScholarĀ 

  2. Gotschlich, E. C., Lepow, M. L., and Gold, R. (1977) The immune response to bacterial polysaccharides in man, in Antibodies in Human Diagnostics and Therapy (Haber, E. and Krause, R. M., eds.), Raven Press, New York, pp. 391ā€“402.

    Google ScholarĀ 

  3. Jennings, H. J. and Sood, R. K. (1994) Synthetic glycoconjugates as human vaccines, in Neoglycoconjugates: Preparation and Applications (Lee, Y. C. and Lee, R. T., eds.), Academic Press, San Diego, pp. 325ā€“371.

    Google ScholarĀ 

  4. Jennings, H. J. and Lugowski, C. (1981) Immunochemistry of group A, B and C meningococcal polysaccharide-tetanus toxoid conjugates. J. Immunol. 127, 1011ā€“1018.

    CASĀ  PubMedĀ  Google ScholarĀ 

  5. Schwartz, B. A. and Gray, G. R. (1977) Proteins containing reductively animated disaccharides. Synthesis and chemical characterization. Arch. Biochem. Biophy. 181, 542ā€“549.

    ArticleĀ  CASĀ  Google ScholarĀ 

  6. Beuvery, E. C., Roy, R., Kanhai, V., and Jennings, H. J. (1986) Characteristics of two types of meningococcal group C polysaccharide conjugates using tetanus toxoid as carrier protein. Dev. Biol. Stand. 65, 197ā€“204.

    CASĀ  PubMedĀ  Google ScholarĀ 

  7. Bhattacharjee, A. K., Jennings, H. J., Kenny, C. P., Martin, A., and Smith, I. C. P. (1975) Structural determination of the sialic acid polysaccharide antigens of Neisseria mentingitis serogroups B and C with carbon 13 nuclear magnetic resonance. J. Biol. Chem. 250, 1926ā€“1932.

    CASĀ  PubMedĀ  Google ScholarĀ 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

Ā© 2001 Humana Press Inc., Totowa, NJ

About this protocol

Cite this protocol

Guo, Z., Jennings, H. (2001). Protein-Polysaccharide Conjugation. In: Pollard, A.J., Maiden, M.C. (eds) Meningococcal Vaccines. Methods in Molecular Medicineā„¢, vol 66. Humana Press. https://doi.org/10.1385/1-59259-148-5:49

Download citation

  • DOI: https://doi.org/10.1385/1-59259-148-5:49

  • Publisher Name: Humana Press

  • Print ISBN: 978-0-89603-801-1

  • Online ISBN: 978-1-59259-148-0

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics